T1	SNP 224 234	rs11571833
T2	Entity 239 244	A > T
R1	Nucleotide_substitution Arg1:T1 Arg2:T2	
T3	Entity 353 358	K3326
R2	SNP_allele Arg1:T1 Arg2:T3	
T4	Spec 413 426	some evidence
T5	Association 471 475	risk
E1	Association:T5 bc:T7 snp_int:T1
R3	Speculation_marker Arg1:E1 Arg2:T4	
T6	Effect_Type 461 470	increased
A1	Effect_Type E1 Increase
R4	Effect_type_marker Arg1:E1 Arg2:T6	
T7	Cancer 479 492	breast cancer
T8	Entity 306 330	creation of a stop codon
R5	SNP_type Arg1:T1 Arg2:T8	
A3	SNP_Type T1 Nonsense
T9	SNP 720 731	the variant
R6	Equiv Arg1:T9 Arg2:T1	
T10	Effect_Type 800 810	enrichment
T11	Cancer 818 831	breast cancer
T12	Association 800 810	enrichment
E2	Association:T12 snp_int:T9 bc:T11
A5	Effect_Type E2 Increase
R7	Effect_type_marker Arg1:E2 Arg2:T10	
T13	SNP 941 953	this variant
R8	Equiv Arg1:T13 Arg2:T9	
T14	Spec 925 935	suggesting
T15	Association 999 1003	risk
E3	Association:T15 
R9	Speculation_marker Arg1:E3 Arg2:T14	
T16	Cancer 985 998	breast cancer
R10	Equiv Arg1:T13 Arg2:T16	
T17	SNP 1005 1015	rs11571833
T18	Spec 1058 1068	evaluating
T19	Association 1083 1087	risk
E4	Association:T19 bc:T20 snp_int:T17
R11	Speculation_marker Arg1:E4 Arg2:T18	
T20	Cancer 1069 1082	breast cancer
T21	Entity 20 25	BRCA2
R12	SNP_coupled_gene Arg1:T1 Arg2:T21	
T22	SNP 44 55	c.9976A > T
T23	Organic_inorganic_molecules_affected 306 351	creation of a stop codon 93 amino acids early
E5	Organic_inorganic_molecules_affected:T23 Agent:T1 Theme:T26 Theme2:T3
T24	SNP 57 69	p.Lys3326Ter
R13	Equiv Arg1:T1 Arg2:T22	
R14	Equiv Arg1:T1 Arg2:T24	
T25	Spec 0 12	Reevaluation
T26	Entity 59 69	Lys3326Ter
T27	Cancer 76 98	familial breast cancer
A8	Cancer_Type T27 Familial
T28	Association 99 106	context
E6	Association:T28 bc:T27 snp_int:T22
R15	Speculation_marker Arg1:E6 Arg2:T25	
T29	Entity 50 55	A > T
R16	Nucleotide_substitution Arg1:T22 Arg2:T29	
R17	Equiv Arg1:T22 Arg2:T24	
R18	Equiv Arg1:T11 Arg2:T27	
A2	SNP_Type T22 Missense
A4	SNP_Type T24 Missense
A6	SNP_Type T17 Missense
